EMD-49835

Single-particle
3.0 Å
EMD-49835
3D View Gallery
Deposition: 20/03/2025
Map released: 25/02/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-49835

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9nvg summary report (pdf.gz) Map-9nvg FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 BA.1 S6P (HexaPro) + COV2-3835 Fab Local Refinement Map (RBD + Fv)

EMD-49835

Single-particle
3.0 Å
EMD-49835
3D View Gallery
Deposition: 20/03/2025
Map released: 25/02/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 BA.1 S6P (HexaPro) + COV2-3835 Fab
Fitted models: 9nvg

Deposition Authors: Ramamohan AR , Johnson NV , McLellan JS
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants.
Zost SJ , Suryadevara N , Williamson LE , Scheaffer SM, Binshtein E, Buchman CD , Johnson NV , Catanzaro NJ , Ravera S, Chapman NS, Myers L , Ramamohan AR , Handal LS , Nguyen DC , Trivette A, Martinez JR , Villalobos E , Rutherford SA, Eun-Hyung Lee F , Schafer A , Baric RS , McLellan JS , Diamond MS , Carnahan RH , Crowe Jr JE
(2026) Nat Microbiol , 11 , 1113 - 1132
PUBMED: 41820555
DOI: doi:10.1038/s41564-026-02282-x
ISSN: 2058-5276
Grant Support: